NVR Equity Method Investments decreased by 11.8% to $68.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 82.8%, from $37.70M to $68.90M.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.70M | $20.80M | $18.80M | $30.00M | $27.80M | $26.80M | $27.60M | $28.10M | $28.10M | $27.10M | $27.80M | $37.70M | $65.50M | $66.50M | $78.10M | $68.90M |
| QoQ Change | — | -4.1% | -9.6% | +59.6% | -7.3% | -3.6% | +3.0% | +1.8% | +0.0% | -3.6% | +2.6% | +35.6% | +73.7% | +1.5% | +17.4% | -11.8% |
| YoY Change | — | — | — | +38.2% | +33.7% | +42.6% | -8.0% | +1.1% | +4.9% | -1.8% | -1.1% | +34.2% | +141.7% | +139.2% | — | +82.8% |